“Katherine is that rare talent that understands the full lifecycle of biotech from startup through development, regulatory and commercialization. Her services in the seed round prior to my joining the company were invaluable in helping the founders focus and create a strategic plan that was integral to our successfully raising a $12 Million Series A financing with a lead investor that was introduced to us by Katherine.  We continue to utilize her expertise in helping us assess the reimbursement landscape as we plan for commercialization.   Further, we continue to benefit from her network of relationships across the diagnostics industry with referral to additional professionals with relevant experience.”